Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography

Pancreas

Volumn 26, Issue 4, 2003, Pages 375-380

  Chen, Chun Chia ^a   Wang, Sun Sang ^a   Lu, Rei Hwa ^a   Lu, Cheng Chung ^a   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Acute pancreatitis; Cytokines; Endoscopic retrograde cholangiopancreatography (ERCP)

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MARKER; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PANCREATITIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038067980     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200305000-00011     Document Type: Article

References (26)

1. Skude G, Wehlin L, Maruyama T, et al. Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography. Gut 1976;17:127-132.
2. Fjosne U, Waldum HL, Romslo I, et al. Amylase, pancreatic isoamylase and lipase in serum before and after endoscopic pancreatography. Acta Med Scand 1986;219:301-304.
3. LaFerla G, Gordon S, Archibald M, et al. Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas 1986;1:160-163.
4. Gottlieb K, Sherman S, Pezzi J, et al. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 1996;91:1553-1557.
5. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-435.
6. Sherman S, Lehman GA. ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991;6:350-367.
7. Testoni PA, Bagnolo F, Caporuscio S, et al. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol 1999;94:1235-1241.
8. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-785.
9. Heath DI, Cruickshank A, Gudgeon M, et al. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-45.
10. Gross V, Leser HG, Andreesen R, et al. Interleukin-8 (IL-8) and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-203.
11. Exley AR, Leese T, Holloday MP, et al. Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-1128.
12. Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-218.
13. Chen CC, Wang SS, Lu RH, et al. Serum interleukin-10 and interleukin-11 in patients with acute pancreatitis. Gut 1999;45:895-899.
14. Berney T, Gasche Y, Robert J, et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999;18:371-377.
15. Mayer J, Rau B, Gansauge F, et al. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000;47:546-552.
16. Messmann H, Vogt W, Holstege A, et al. Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997;40:80-85.
17. Messmann H, Vogt W, Falk W, et al. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis. Eur J Gastroenterol Hepatol 1998;10:611-617.
18. Wozniak B, Wisniewska-Jarosinska M, Drzewoski J. Evaluation of selected parameters of the inflammatory response to endoscopic retrograde cholangiopan-creatography. Pancreas 2001;23:349-355.
19. Petersson U, Borgström A, Ohlsson K, et al. Enzymes leakage, trypsinogen activation, and inflammatory response in endoscopic retrograde cholangiopan-creatography-induced pancreatitis. Pancreas 2002;24:321-328.
20. Bradley EL III. A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute pancreatitis. Atlanta, GA, September II through 13, 1992. Arch Surg 1993;128:586-590.
21. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299:926-930.
22. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
23. Oezcueruemez-Porsch M, Kunz D, Hardt PD, et al. Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci 1998;43:1763-1769.
24. Devière J, Le Moine O, Van Laethem JL, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
25. Conn M, Goldenberg A, Concepcion L, et al. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors. Am J Gastroenterol 1991;86:1011-1014.
26. Cunliffe WJ, Cobden LI, Lavelle MI, et al. A randomized prospective study comparing two contrast media in ERCP. Endoscopy 1987;19:201-202.